zip >>> 10016
sector >>> Healthcare
fullTimeEmployees >>> 30000
longBusinessSummary >>> Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products in the following therapeutic classes: hematology, oncology, cardiovascular, and immunology. The company's products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, it offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, and Ubiquigent Limited; clinical collaboration agreement with NeoImmuneTech, Inc.; and partnership with Astrazeneca Plc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
city >>> New York
phone >>> 212 546 4000
state >>> NY
country >>> United States
companyOfficers >>> []
website >>> http://www.bms.com
maxAge >>> 1
address1 >>> 430 East 29th Street
industry >>> Drug Manufacturers—General
address2 >>> 14th Floor
previousClose >>> 58.25
regularMarketOpen >>> 58.26
twoHundredDayAverage >>> 59.117336
trailingAnnualDividendYield >>> 0.030214593
payoutRatio >>> None
volume24Hr >>> None
regularMarketDayHigh >>> 59.84
navPrice >>> None
averageDailyVolume10Day >>> 11552314
totalAssets >>> None
regularMarketPreviousClose >>> 58.25
fiftyDayAverage >>> 60.93206
trailingAnnualDividendRate >>> 1.76
open >>> 58.26
toCurrency >>> None
averageVolume10days >>> 11552314
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> 1.8
exDividendDate >>> 1601510400
beta >>> 0.6767
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 58.1567
priceHint >>> 2
currency >>> USD
regularMarketVolume >>> 9577334
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 134086295552
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 9964328
priceToSalesTrailing12Months >>> 3.8462021
dayLow >>> 58.1567
ask >>> 59.48
ytdReturn >>> None
askSize >>> 1100
volume >>> 9577334
fiftyTwoWeekHigh >>> 68.34
forwardPE >>> 7.995968
fromCurrency >>> None
fiveYearAvgDividendYield >>> 2.76
fiftyTwoWeekLow >>> 45.76
bid >>> 59.52
tradeable >>> False
dividendYield >>> 0.0309
bidSize >>> 800
dayHigh >>> 59.84
exchange >>> NYQ
shortName >>> Bristol-Myers Squibb Company
longName >>> Bristol-Myers Squibb Company
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EDT
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -14400000
quoteType >>> EQUITY
symbol >>> BMY
messageBoardId >>> finmb_25798
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 4.586
beta3Year >>> None
profitMargins >>> -0.01615
enterpriseToEbitda >>> 11.416
52WeekChange >>> 0.17314148
morningStarRiskRating >>> None
forwardEps >>> 7.44
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 2253929984
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 21.781
sharesShort >>> 14364173
sharesPercentSharesOut >>> 0.0064
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.79093003
netIncomeToCommon >>> -563000000
trailingEps >>> -0.279
lastDividendValue >>> None
SandP52WeekChange >>> 0.108078
priceToBook >>> 2.7312796
heldPercentInsiders >>> 0.0011100001
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1593475200
shortRatio >>> 1.56
sharesShortPreviousMonthDate >>> 1597363200
floatShares >>> 2250959441
enterpriseValue >>> 159869566976
threeYearAverageReturn >>> None
lastSplitDate >>> 997142400
lastSplitFactor >>> 1000000:951777
legalType >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> None
dateShortInterest >>> 1600128000
pegRatio >>> 0.42
lastCapGain >>> None
shortPercentOfFloat >>> 0.0064
sharesShortPriorMonth >>> 14453167
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 58.26
logo_url >>> https://logo.clearbit.com/bms.com
